COLZYX
Lund · Founded 2016 · $7.2M raised
- Headquarters
- Lund
- Founded
- 2016
- Business Model
- B2B
- Website
- colzyx.com
- Total Funding
- $7.2M
- Last Round
- $1.2M SeedJan 2021
- Rounds
- 2
About
COLZYX is a Swedish biotech company based at Medicon Village in Lund developing WOUNDCOM, a bioactive collagen-based wound dressing designed to combat multidrug-resistant bacteria in chronic, hard-to-heal wounds. Its technology mirrors the body's own antimicrobial peptide defense system to accelerate healing while addressing rising antibiotic resistance, and its collagen matrix is also used as a research reagent in academic wound-healing studies.
Summary
COLZYX is a Biotech company based in Lund, founded in 2016. It has raised $7.2M in total across 2 rounds, most recently a $1.2M Seed round in Jan 2021. Investors include European Innovation Council Fund and European Investment Fund.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company